ADCT
ADC Therapeutics S.A.
NYSE · CHHealthcareBiotechnology
$1.26-6.67%
Price as of Jul 20, 2026
ADCT valuation
ADC Therapeutics S.A. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 11.02x
- P/S forward
- 4.08x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.74x
- Price / sales
- 2.02x
- Price / cash flow
- -1.40x
Enterprise value
- Enterprise value
- $45.9M
- EV / sales
- 0.58x
- EV / EBITDA
- -0.55x
- EV / EBIT
- -0.39x
- Market cap
- $160.3M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.